[Surgical treatment of esophageal cancer].
Prospective study, included 117 patients with esophageal cancer, all received resection of the esophagus through laparatomy and and right-side thoracotomy without neoadjuvant chemotherapy. 70,0% of patients demonstrated stage higher then IIb UICC. R0 resection was possible in 101 patients (86,3%). Hospital lethality was 5,1%. Overall lethality among the operated patients was 21,4%. Long-term follow-up results were obtained in 96,6%. Surgical treatment alone does not provide satisfactory results for the patients with cancer of esophagus. Further therapy individualization and combination of surgery with modern neoadjuvant chemotherapy can provide better prognosis for these patients.
Kube
R
R
Reimer
A
A
Laube
T
T
Gastinger
I
I
D004938:Esophageal Neoplasms / Q000401:mortality / Q000601:surgery*; D016629:Esophagectomy / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007813:Laparotomy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D015996:Survival Rate / Q000639:trends; D013908:Thoracotomy / Q000379:methods*; D013997:Time Factors; D016896:Treatment Outcome